Literature DB >> 27273977

Fuchs' endothelial corneal dystrophy: a controlled prospective study on visual recovery after endothelial keratoplasty.

Esben Nielsen1, Anders Ivarsen1, Simon Kristensen2, Jesper Hjortdal1.   

Abstract

PURPOSE: To investigate the determining factors of vision and subjective outcome after Descemet's stripping automated endothelial keratoplasty (DSAEK) for Fuchs' endothelial dystrophy (FECD).
METHODS: In a prospective study, 41 FECD patients who received DSAEK were compared to 40 cataract patients with normal corneas who received cataract surgery (control group). Subjects were recruited between March 2013 and July 2014. Observational procedures included the following: best-corrected visual acuity (BCVA), contrast sensitivity (CS), Catquest-9SF questionnaire, Scheimpflug tomography and anterior OCT. Examinations were carried out before surgery and at 3-, 6- and 12-month follow-up. Main outcome measures were associations between corneal optics and visual parameters, as well as subjective improvement (Catquest-9SF effect size)
RESULTS: Best-corrected visual acuity (BCVA) negatively correlated with anterior higher-order aberrations (HOA's) (p < 0.001) and central corneal thickness (p = 0.001). Contrast sensitivity (CS) was negatively correlated with anterior HOA's (p = 0.002) and positively correlated with posterior densitometry (p = 0.008). Catquest-9SF effect size was 1.32 (CI: 1.0-1.6) in the control group, 1.84 (CI: 1.4-2.3) in FECD patients who received phacoemulsification and intra-ocular lens implantation in combination with DSAEK (n = 26) and 1.37 (CI: 0.6-2.1) in pseudophakic FECD patients who received DSAEK (n = 15).
CONCLUSIONS: DSAEK surgery leads to considerable improvement in patient-reported outcome in FECD patients. There was a strong correlation between anterior HOA's and vision after DSAEK, suggesting that anterior corneal pathology constitutes the major limitation for visual recovery after DSAEK.
© 2016 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Descemet's stripping automated endothelial keratoplasty; Fuchs’ endothelial corneal dystrophy; corneal transplantation; descemet stripping automated endothelial keratoplasty; endothelial keratoplasty

Mesh:

Year:  2016        PMID: 27273977     DOI: 10.1111/aos.13126

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Corneal Higher-Order Aberrations in Descemet Membrane Endothelial Keratoplasty versus Ultrathin DSAEK in the Descemet Endothelial Thickness Comparison Trial: A Randomized Clinical Trial.

Authors:  Matthew J Duggan; Jennifer Rose-Nussbaumer; Charles C Lin; Ariana Austin; Paula C Labadzinzki; Winston D Chamberlain
Journal:  Ophthalmology       Date:  2019-02-16       Impact factor: 12.079

2.  Corneal Light Scatter After Ultrathin Descemet Stripping Automated Endothelial Keratoplasty Versus Descemet Membrane Endothelial Keratoplasty in Descemet Endothelial Thickness Comparison Trial: A Randomized Controlled Trial.

Authors:  Kristin E Hirabayashi; Winston Chamberlain; Jennifer Rose-Nussbaumer; Ariana Austin; Laurel Stell; Charles C Lin
Journal:  Cornea       Date:  2020-06       Impact factor: 2.651

3.  One-year natural course of corneal densitometry in high myopic patients after implantation of an implantable collamer lens (model V4c).

Authors:  Xun Chen; Yang Shen; Haipeng Xu; Xiaoying Wang; Xingtao Zhou
Journal:  BMC Ophthalmol       Date:  2020-02-12       Impact factor: 2.209

4.  Anterior Chamber Characteristics, Endothelial Parameters, and Corneal Densitometry After Descemet Stripping Automated Endothelial Keratoplasty in Patients With Fuchs Dystrophy.

Authors:  Remzi Karadag; Kristin M Hammersmith; Parveen K Nagra; Christopher J Rapuano
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

5.  Quality of vision and vision-related quality of life after Descemet membrane endothelial keratoplasty: a randomized clinical trial.

Authors:  Suryan L Dunker; Mor M Dickman; Robert P L Wisse; Siamak Nobacht; Robert H J Wijdh; Marjolijn C Bartels; N E Mei-Lie Tang; Frank J H M van den Biggelaar; Pieter J Kruit; Bjorn Winkens; Rudy M M A Nuijts
Journal:  Acta Ophthalmol       Date:  2021-01-12       Impact factor: 3.761

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.